CT-322: Clinical Trials

3 trials of CT-322, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Unknown 1, Withdrawn 1

Follow CT-322: new trials by email Literature Review of CT-322 trials Research Report on CT-322

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Japanese Phase 1 Study of BMS-844203 (CT322)
BMS-844203 (CT-322) - Neoplasms
Phase 1WithdrawnBristol-Myers Squibb2013-11-012012-02-07
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
CT-322, Temozolomide, Radiation Therapy - Glioblastoma Multiforme
Phase 1UnknownAdnexus, A Bristol-Myers Squibb R&D Company302008-10-012010-10-27
CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
CT-322 - Cancer
Phase 1CompletedAdnexus, A Bristol-Myers Squibb R&D Company402006-08-012009-02-24

Conditions studied

Neoplasms (2)  ·  Glioblastoma (1)

Sponsors

Adnexus, A Bristol-Myers Squibb R&D Company (2)  ·  Bristol-Myers Squibb (1)

Countries

United States (2)  ·  Japan (1)

Results publications

PMID 21224368